Literature DB >> 34050818

Hand surgeons and amyloidosis specialists warning: transthyretin-associated amyloidosis with bifid median nerve as a cause of bilateral carpal tunnel syndrome. A case report and literature review.

Andreu Triguero1,2, José González-Costello2,3, Silvia López-Marne1,2, Alfred Llop1,2, Maria Pané2,4, Sergi Yun5,6,7.   

Abstract

INTRODUCTION: Approximately 75% of patients with carpal tunnel syndrome (CTS) are diagnosed as idiopathic. Despite this, the presence of an underlying cause such as an anatomical variant or a systemic disease must always be suspected, especially in cases of bilateral presentation without an obvious cause, recurrence or complications. The anatomical variant known as the bifid median nerve (BMN) is a very rare abnormality that can occasionally lead to CTS. On the other hands, transthyretin-associated amyloidosis (ATTR) is one of the possible causes of bilateral CTS. We report a case where these two very rare pathologies converge as the cause of bilateral CTS and a review of the literature. CASE REPORT: We report a 71-year-old male with prior history of lumbar canal stenosis, bilateral trigger finger, rupture of the supraspinatus muscle tendon and of the long portion of the right biceps brachial. He also had 8-year-old bilateral CTS that recurred after CTS surgery. He was surgically re-intervened and was diagnosed incidentally with BMN and an ultrasound of the other hands also showed BMN. Because of all the prior musculoskeletal history, a biopsy of the transverse carpal ligament was taken showing ATTR deposits that led to the diagnosis of cardiac ATTR wild type.
CONCLUSIONS: This case highlights the natural history of the multiple musculoskeletal manifestations related to ATTR and the importance of performing intraoperative biopsies in patients with CTS surgery as this can lead to early diagnosis of cardiac ATTR.
© 2021. The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature.

Entities:  

Keywords:  Bifid median nerve; Cardiac amyloidosis; Carpal tunnel syndrome; Transthyretin-associated wild-type amyloidosis (ATTRwt)

Mesh:

Substances:

Year:  2021        PMID: 34050818     DOI: 10.1007/s00590-021-03004-1

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  13 in total

1.  Bifid median nerve in patients with carpal tunnel syndrome.

Authors:  Ilkay Koray Bayrak; Ayse Oytun Bayrak; Melike Kale; Hande Turker; Baris Diren
Journal:  J Ultrasound Med       Date:  2008-08       Impact factor: 2.153

2.  High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly.

Authors:  Yoshiki Sekijima; Shigeharu Uchiyama; Kana Tojo; Kenji Sano; Yusaku Shimizu; Toshihiko Imaeda; Yoshibonu Hoshii; Hiroyuki Kato; Shu-ichi Ikeda
Journal:  Hum Pathol       Date:  2011-11       Impact factor: 3.466

3.  [Transthyretin amyloidosis: What we now see is just the tip of the iceberg].

Authors:  Sergi Yun; José González-Costello; Francesc Formiga
Journal:  Rev Esp Geriatr Gerontol       Date:  2020-06-20

4.  Anatomical variations of the median nerve in the carpal tunnel.

Authors:  U Lanz
Journal:  J Hand Surg Am       Date:  1977-01       Impact factor: 2.230

Review 5.  Carpal Tunnel Syndrome: A Potential Early, Red-Flag Sign of Amyloidosis.

Authors:  Joseph P Donnelly; Mazen Hanna; Brett W Sperry; William H Seitz
Journal:  J Hand Surg Am       Date:  2019-08-07       Impact factor: 2.230

6.  Carpal tunnel release: Lifetime prevalence, annual incidence, and risk factors.

Authors:  Mohammad-Hossein Pourmemari; Markku Heliövaara; Eira Viikari-Juntura; Rahman Shiri
Journal:  Muscle Nerve       Date:  2018-05-18       Impact factor: 3.217

7.  Prevalence of carpal tunnel syndrome in a general population.

Authors:  I Atroshi; C Gummesson; R Johnsson; E Ornstein; J Ranstam; I Rosén
Journal:  JAMA       Date:  1999-07-14       Impact factor: 56.272

8.  Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies.

Authors:  Agnese Milandri; Andrea Farioli; Christian Gagliardi; Simone Longhi; Fabrizio Salvi; Stefania Curti; Serena Foffi; Angelo Giuseppe Caponetti; Massimiliano Lorenzini; Alessandra Ferlini; Paola Rimessi; Stefano Mattioli; Francesco Saverio Violante; Claudio Rapezzi
Journal:  Eur J Heart Fail       Date:  2020-01-23       Impact factor: 15.534

9.  Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release.

Authors:  Brett W Sperry; Bryan A Reyes; Asad Ikram; Joseph P Donnelly; Dermot Phelan; Wael A Jaber; David Shapiro; Peter J Evans; Steven Maschke; Scott E Kilpatrick; Carmela D Tan; E Rene Rodriguez; Cecilia Monteiro; W H Wilson Tang; Jeffery W Kelly; William H Seitz; Mazen Hanna
Journal:  J Am Coll Cardiol       Date:  2018-10-23       Impact factor: 24.094

10.  Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.

Authors:  Julian D Gillmore; Mathew S Maurer; Rodney H Falk; Giampaolo Merlini; Thibaud Damy; Angela Dispenzieri; Ashutosh D Wechalekar; John L Berk; Candida C Quarta; Martha Grogan; Helen J Lachmann; Sabahat Bokhari; Adam Castano; Sharmila Dorbala; Geoff B Johnson; Andor W J M Glaudemans; Tamer Rezk; Marianna Fontana; Giovanni Palladini; Paolo Milani; Pierluigi L Guidalotti; Katarina Flatman; Thirusha Lane; Frederick W Vonberg; Carol J Whelan; James C Moon; Frederick L Ruberg; Edward J Miller; David F Hutt; Bouke P Hazenberg; Claudio Rapezzi; Philip N Hawkins
Journal:  Circulation       Date:  2016-04-22       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.